EXC
53
6
O
31
3
ED
53
4
MAS
67
-3
UA
32
8
MPC
52
8
EMN
70
-2
ADM
33
-3
PGR
68
3
BBY
56
-2
DOW
58
-5
USB
44
-3
PG
51
3
DHR
56
-4
KMI
59
2
AMP
66
-4
TGT
50
-2
PNC
57
-2
VRTX
53
-2
MOS
19
-4
EXC
53
6
O
31
3
ED
53
4
MAS
67
-3
UA
32
8
MPC
52
8
EMN
70
-2
ADM
33
-3
PGR
68
3
BBY
56
-2
DOW
58
-5
USB
44
-3
PG
51
3
DHR
56
-4
KMI
59
2
AMP
66
-4
TGT
50
-2
PNC
57
-2
VRTX
53
-2
MOS
19
-4
Financhill
Back

Black Diamond Therapeutics Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
38

BDTX
Black Diamond Therapeutics

Last Price:
4.76
Seasonality Move:
-24.01%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
38
Black Diamond Therapeutics (BDTX) is a Sell

Is Black Diamond Therapeutics a Buy, Sell or Hold?

  • The current Black Diamond Therapeutics [BDTX] share price is $4.76. The Score for BDTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • BDTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BDTX Stock Price Chart

What is Black Diamond Therapeutics's stock price today?

  • The Black Diamond Therapeutics share price today is $4.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

BDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 38.31 Sell
Chaikin Money Flow: 350174 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.21 - 6.31) Sell
Bollinger Bands (100): (4.79 - 6.21) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

BDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.33 Sell
20-day SMA: 5.73 Sell
50-day SMA: 5.69 Sell
200-day SMA: 4.78 Sell
8-day EMA: 5.16 Sell
20-day EMA: 5.47 Sell
50-day EMA: 5.54 Sell
200-day EMA: 4.85 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Black Diamond Therapeutics Earnings Growth & BDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.57 per share, and a decrease next year of $0.14 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Black Diamond Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):